$DKS just another example of an optically cheap stock getting taken out the back and shot. No real valuation floor in this market if you're going to miss to that extent. We've left money on the table a number of times on the short side by covering names that are facing issues but start to look cheap, and then subsequently leg down massively. Those "cheap" but challenged stocks where their issues are worsening often make the best shorts vs trying to find another player in the space that's better quality/higher multiple. But also important to balance the willingness to short something that's cheap with knowing when to cover once the 2nd derivative flips positive and investors will find ways to start getting positive on the story again. There's usually the risk of extrapolating recent negative trends, overstaying your welcome, and then roundtripping any gains on the short once the mkt starts to look through to the recovery.